GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Stock Based Compensation

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Stock Based Compensation : €0.00 Mil (TTM As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Stock Based Compensation?

Oxford Cannabinoid Technologies Holdings's Stock Based Compensation for the six months ended in Oct. 2023 was €0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2023 was €0.00 Mil.


Oxford Cannabinoid Technologies Holdings Stock Based Compensation Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Stock Based Compensation Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Stock Based Compensation
- 0.05 0.16 1.18 0.07

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only - - - - -

Oxford Cannabinoid Technologies Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Oct. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


Oxford Cannabinoid Technologies Holdings Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines